Cargando…
Molecular classification grade 3 endometrial endometrioid carcinoma using a next-generation sequencing–based gene panel
Over the past two decades, the incidence of endometrial cancer (EC) is increasing, and there is a need for molecular biomarkers to predict prognosis and guide treatment. A recent study from The Cancer Genome Atlas suggested to implement the EC analysis by molecular profile for improving diagnosis, p...
Autores principales: | Li, Ling, Chen, Fangfang, Liu, Jingcheng, Zhu, Weifeng, Lin, Liang, Chen, Li, Shi, Yi, Lin, An, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394115/ https://www.ncbi.nlm.nih.gov/pubmed/36003784 http://dx.doi.org/10.3389/fonc.2022.935694 |
Ejemplares similares
-
Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing
por: Wang, Yao, et al.
Publicado: (2019) -
Combined deep-learning MRI-based radiomic models for preoperative risk classification of endometrial endometrioid adenocarcinoma
por: Yang, Jin, et al.
Publicado: (2023) -
Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020) -
An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer
por: Zou, Jing, et al.
Publicado: (2012) -
The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)